Long-Term Coffee Consumption and Risk of Cardiovascular Disease: A Systematic Review and a Dose–Response Meta-Analysis of Prospective Cohort Studies
BACKGROUND—Considerable controversy exists on the association between coffee consumption and cardiovascular disease (CVD) risk. A meta-analysis was performed to assess the dose–response relationship of long-term coffee consumption with CVD risk. METHODS AND RESULTS—PubMed and EMBASE were searched fo...
Saved in:
| Published in | Circulation (New York, N.Y.) Vol. 129; no. 6; pp. 643 - 659 |
|---|---|
| Main Authors | , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Hagerstown, MD
by the American College of Cardiology Foundation and the American Heart Association, Inc
11.02.2014
Lippincott Williams & Wilkins |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | BACKGROUND—Considerable controversy exists on the association between coffee consumption and cardiovascular disease (CVD) risk. A meta-analysis was performed to assess the dose–response relationship of long-term coffee consumption with CVD risk.
METHODS AND RESULTS—PubMed and EMBASE were searched for prospective cohort studies of the relationship between coffee consumption and CVD risk, which included coronary heart disease, stroke, heart failure, and CVD mortality. Thirty-six studies were included with 1 279 804 participants and 36 352 CVD cases. A nonlinear relationship of coffee consumption with CVD risk was identified (P for heterogeneity=0.09, P for trend <0.001, P for nonlinearity <0.001). Compared with the lowest category of coffee consumption (median, 0 cups per day), the relative risk of CVD was 0.95 (95% confidence interval, 0.87–1.03) for the highest category (median, 5 cups per day) category, 0.85 (95% confidence interval, 0.80–0.90) for the second highest category (median, 3.5 cups per day), and 0.89 (95% confidence interval, 0.84–0.94) for the third highest category (median, 1.5 cups per day). Looking at separate outcomes, coffee consumption was nonlinearly associated with both coronary heart disease (P for heterogeneity=0.001, P for trend <0.001, P for nonlinearity <0.001) and stroke (P for heterogeneity=0.07, P for trend <0.001, P for nonlinearity <0.001; P for trend differences >0.05) risks.
CONCLUSIONS—A nonlinear association between coffee consumption and CVD risk was observed in this meta-analysis. Moderate coffee consumption was inversely significantly associated with CVD risk, with the lowest CVD risk at 3 to 5 cups per day, and heavy coffee consumption was not associated with elevated CVD risk. |
|---|---|
| AbstractList | BACKGROUND—Considerable controversy exists on the association between coffee consumption and cardiovascular disease (CVD) risk. A meta-analysis was performed to assess the dose–response relationship of long-term coffee consumption with CVD risk.
METHODS AND RESULTS—PubMed and EMBASE were searched for prospective cohort studies of the relationship between coffee consumption and CVD risk, which included coronary heart disease, stroke, heart failure, and CVD mortality. Thirty-six studies were included with 1 279 804 participants and 36 352 CVD cases. A nonlinear relationship of coffee consumption with CVD risk was identified (P for heterogeneity=0.09, P for trend <0.001, P for nonlinearity <0.001). Compared with the lowest category of coffee consumption (median, 0 cups per day), the relative risk of CVD was 0.95 (95% confidence interval, 0.87–1.03) for the highest category (median, 5 cups per day) category, 0.85 (95% confidence interval, 0.80–0.90) for the second highest category (median, 3.5 cups per day), and 0.89 (95% confidence interval, 0.84–0.94) for the third highest category (median, 1.5 cups per day). Looking at separate outcomes, coffee consumption was nonlinearly associated with both coronary heart disease (P for heterogeneity=0.001, P for trend <0.001, P for nonlinearity <0.001) and stroke (P for heterogeneity=0.07, P for trend <0.001, P for nonlinearity <0.001; P for trend differences >0.05) risks.
CONCLUSIONS—A nonlinear association between coffee consumption and CVD risk was observed in this meta-analysis. Moderate coffee consumption was inversely significantly associated with CVD risk, with the lowest CVD risk at 3 to 5 cups per day, and heavy coffee consumption was not associated with elevated CVD risk. Considerable controversy exists on the association between coffee consumption and cardiovascular disease (CVD) risk. A meta-analysis was performed to assess the dose-response relationship of long-term coffee consumption with CVD risk. PubMed and EMBASE were searched for prospective cohort studies of the relationship between coffee consumption and CVD risk, which included coronary heart disease, stroke, heart failure, and CVD mortality. Thirty-six studies were included with 1 279 804 participants and 36 352 CVD cases. A nonlinear relationship of coffee consumption with CVD risk was identified (P for heterogeneity=0.09, P for trend <0.001, P for nonlinearity <0.001). Compared with the lowest category of coffee consumption (median, 0 cups per day), the relative risk of CVD was 0.95 (95% confidence interval, 0.87-1.03) for the highest category (median, 5 cups per day) category, 0.85 (95% confidence interval, 0.80-0.90) for the second highest category (median, 3.5 cups per day), and 0.89 (95% confidence interval, 0.84-0.94) for the third highest category (median, 1.5 cups per day). Looking at separate outcomes, coffee consumption was nonlinearly associated with both coronary heart disease (P for heterogeneity=0.001, P for trend <0.001, P for nonlinearity <0.001) and stroke (P for heterogeneity=0.07, P for trend <0.001, P for nonlinearity <0.001; P for trend differences >0.05) risks. A nonlinear association between coffee consumption and CVD risk was observed in this meta-analysis. Moderate coffee consumption was inversely significantly associated with CVD risk, with the lowest CVD risk at 3 to 5 cups per day, and heavy coffee consumption was not associated with elevated CVD risk. Considerable controversy exists on the association between coffee consumption and cardiovascular disease (CVD) risk. A meta-analysis was performed to assess the dose-response relationship of long-term coffee consumption with CVD risk.BACKGROUNDConsiderable controversy exists on the association between coffee consumption and cardiovascular disease (CVD) risk. A meta-analysis was performed to assess the dose-response relationship of long-term coffee consumption with CVD risk.PubMed and EMBASE were searched for prospective cohort studies of the relationship between coffee consumption and CVD risk, which included coronary heart disease, stroke, heart failure, and CVD mortality. Thirty-six studies were included with 1 279 804 participants and 36 352 CVD cases. A nonlinear relationship of coffee consumption with CVD risk was identified (P for heterogeneity=0.09, P for trend <0.001, P for nonlinearity <0.001). Compared with the lowest category of coffee consumption (median, 0 cups per day), the relative risk of CVD was 0.95 (95% confidence interval, 0.87-1.03) for the highest category (median, 5 cups per day) category, 0.85 (95% confidence interval, 0.80-0.90) for the second highest category (median, 3.5 cups per day), and 0.89 (95% confidence interval, 0.84-0.94) for the third highest category (median, 1.5 cups per day). Looking at separate outcomes, coffee consumption was nonlinearly associated with both coronary heart disease (P for heterogeneity=0.001, P for trend <0.001, P for nonlinearity <0.001) and stroke (P for heterogeneity=0.07, P for trend <0.001, P for nonlinearity <0.001; P for trend differences >0.05) risks.METHODS AND RESULTSPubMed and EMBASE were searched for prospective cohort studies of the relationship between coffee consumption and CVD risk, which included coronary heart disease, stroke, heart failure, and CVD mortality. Thirty-six studies were included with 1 279 804 participants and 36 352 CVD cases. A nonlinear relationship of coffee consumption with CVD risk was identified (P for heterogeneity=0.09, P for trend <0.001, P for nonlinearity <0.001). Compared with the lowest category of coffee consumption (median, 0 cups per day), the relative risk of CVD was 0.95 (95% confidence interval, 0.87-1.03) for the highest category (median, 5 cups per day) category, 0.85 (95% confidence interval, 0.80-0.90) for the second highest category (median, 3.5 cups per day), and 0.89 (95% confidence interval, 0.84-0.94) for the third highest category (median, 1.5 cups per day). Looking at separate outcomes, coffee consumption was nonlinearly associated with both coronary heart disease (P for heterogeneity=0.001, P for trend <0.001, P for nonlinearity <0.001) and stroke (P for heterogeneity=0.07, P for trend <0.001, P for nonlinearity <0.001; P for trend differences >0.05) risks.A nonlinear association between coffee consumption and CVD risk was observed in this meta-analysis. Moderate coffee consumption was inversely significantly associated with CVD risk, with the lowest CVD risk at 3 to 5 cups per day, and heavy coffee consumption was not associated with elevated CVD risk.CONCLUSIONSA nonlinear association between coffee consumption and CVD risk was observed in this meta-analysis. Moderate coffee consumption was inversely significantly associated with CVD risk, with the lowest CVD risk at 3 to 5 cups per day, and heavy coffee consumption was not associated with elevated CVD risk. |
| Author | Satija, Ambika Ding, Ming Hu, Frank B. van Dam, Rob M. Bhupathiraju, Shilpa N. |
| AuthorAffiliation | From the Departments of Nutrition (M.D., S.N.B., A.S., R.M.v.D., F.B.H.) and Epidemiology (F.B.H.), Harvard School of Public Health, Boston, MA; Saw Swee Hock School of Public Health and Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore and National University Health System, Singapore (R.M.v.D.); and Channing Division of Network Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA (F.B.H.) |
| AuthorAffiliation_xml | – name: From the Departments of Nutrition (M.D., S.N.B., A.S., R.M.v.D., F.B.H.) and Epidemiology (F.B.H.), Harvard School of Public Health, Boston, MA; Saw Swee Hock School of Public Health and Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore and National University Health System, Singapore (R.M.v.D.); and Channing Division of Network Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA (F.B.H.) – name: 1 Department of Nutrition, Harvard School of Public Health, Boston, MA – name: 2 Saw Swee Hock School of Public Health and Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore and National University Health System, Singapore – name: 3 Department of Epidemiology, Harvard School of Public Health, Boston, MA – name: 4 Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA |
| Author_xml | – sequence: 1 givenname: Ming surname: Ding fullname: Ding, Ming organization: From the Departments of Nutrition (M.D., S.N.B., A.S., R.M.v.D., F.B.H.) and Epidemiology (F.B.H.), Harvard School of Public Health, Boston, MA; Saw Swee Hock School of Public Health and Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore and National University Health System, Singapore (R.M.v.D.); and Channing Division of Network Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA (F.B.H.) – sequence: 2 givenname: Shilpa surname: Bhupathiraju middlename: N. fullname: Bhupathiraju, Shilpa N. – sequence: 3 givenname: Ambika surname: Satija fullname: Satija, Ambika – sequence: 4 givenname: Rob surname: van Dam middlename: M. fullname: van Dam, Rob M. – sequence: 5 givenname: Frank surname: Hu middlename: B. fullname: Hu, Frank B. |
| BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=28231831$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/24201300$$D View this record in MEDLINE/PubMed |
| BookMark | eNqNkstuEzEUhkeoiF7gFZBZILGZ4svcjARolAKNFChK07XleI4b05lxsD2JsuMdkHhAngSHpEBZdXVk-_-_3zrnHCcHve0hSZ4RfEpIQV6OxtPR1aSejS8-1ed1vGOnGOec5g-SI5LTLM1yxg-SI4wxT0tG6WFy7P2XeCxYmT9KDmlGMWEYHyU_Jra_TmfgOjSyWgPE0vuhWwZjeyT7Bk2Nv0FWo5F0jbEr6dXQSofOjAfp4RWq0eXGB-hkMApNYWVg_dsn0Zn18PPb9yn4ZWQC-ghBpnUv2403fov87KxfggpmtY1dWBfQZRgaA_5x8lDL1sOTfT1Jrt6_m43O08nFh_GonqQqp0WeMkw1cK64xEozUhay1A2NJc_kvJS8UFLPqyYvGsbLKseUVJWGImNFWVSANTtJ3uy4y2HeQaOgD062YulMJ91GWGnE3ZfeLMS1XQnGs5wXNAJe7AHOfh3AB9EZr6BtZQ928IJknBNGcVVE6dN_s_6E3A4jCp7vBbHJstVO9sr4v7qKMlIxEnVvdzoV--cdaKFMkNuBxS-aVhAstmsi7q5JvGNityaRwP8j3Ibcx_t6513bNoDzN-2wBicWINuwuIf_F78_2hc |
| CODEN | CIRCAZ |
| CitedBy_id | crossref_primary_10_1016_j_numecd_2018_01_011 crossref_primary_10_3390_ijerph15081661 crossref_primary_10_1016_j_numecd_2018_01_016 crossref_primary_10_1016_j_ihj_2023_12_005 crossref_primary_10_2196_resprot_6267 crossref_primary_10_1016_j_nutres_2017_04_004 crossref_primary_10_1016_j_mcna_2022_04_007 crossref_primary_10_1186_s12986_019_0355_6 crossref_primary_10_1016_j_rmed_2021_106684 crossref_primary_10_3390_molecules29102231 crossref_primary_10_1093_ajcn_nqy369 crossref_primary_10_1016_j_ajpc_2020_100106 crossref_primary_10_1111_joim_12703 crossref_primary_10_1161_CIRCULATIONAHA_115_018585 crossref_primary_10_1186_s12916_022_02636_2 crossref_primary_10_3390_ijms19123988 crossref_primary_10_1038_srep36500 crossref_primary_10_1007_s00394_014_0741_9 crossref_primary_10_1016_j_metabol_2017_06_007 crossref_primary_10_3390_pr8040438 crossref_primary_10_3390_nu16203536 crossref_primary_10_2174_1381612826666201207230956 crossref_primary_10_1016_j_jsps_2020_10_010 crossref_primary_10_2174_0929867328666210708091709 crossref_primary_10_3390_nu14214586 crossref_primary_10_1186_s12986_024_00880_2 crossref_primary_10_1055_a_1221_6985 crossref_primary_10_1021_acs_jmedchem_1c00261 crossref_primary_10_7326_M21_2977 crossref_primary_10_1007_s10151_023_02804_3 crossref_primary_10_1053_j_gastro_2017_11_010 crossref_primary_10_1111_dme_12505 crossref_primary_10_1016_j_tcm_2018_04_008 crossref_primary_10_3945_jn_116_233940 crossref_primary_10_1017_S000711452200040X crossref_primary_10_3390_nu12071970 crossref_primary_10_1002_fsn3_3415 crossref_primary_10_1016_j_neuro_2017_04_008 crossref_primary_10_1142_S0192415X19500162 crossref_primary_10_3390_biomedicines11123242 crossref_primary_10_1136_bmjopen_2015_009809 crossref_primary_10_1136_practneurol_2015_001162 crossref_primary_10_1136_openhrt_2021_001946 crossref_primary_10_1080_08037051_2022_2136621 crossref_primary_10_7554_eLife_85235 crossref_primary_10_1007_s00115_014_4036_4 crossref_primary_10_21101_hygiena_a1765 crossref_primary_10_1038_s41467_022_28240_9 crossref_primary_10_1177_2047487315624524 crossref_primary_10_1002_cncr_34401 crossref_primary_10_1002_jpen_2299 crossref_primary_10_1016_j_jacc_2023_07_029 crossref_primary_10_1007_s00210_025_03826_4 crossref_primary_10_1108_NFS_09_2014_0083 crossref_primary_10_1161_JAHA_117_007155 crossref_primary_10_3389_fnut_2021_738803 crossref_primary_10_1161_STROKEAHA_120_032273 crossref_primary_10_1016_j_ypmed_2019_04_002 crossref_primary_10_1016_j_lanwpc_2023_100955 crossref_primary_10_1039_C4FO00670D crossref_primary_10_1007_s12603_016_0832_9 crossref_primary_10_3897_pharmacia_71_e106817 crossref_primary_10_1053_j_ajkd_2018_01_030 crossref_primary_10_3390_nu13020630 crossref_primary_10_1093_ajcn_nqy297 crossref_primary_10_3390_ph15070872 crossref_primary_10_1038_s41430_018_0346_0 crossref_primary_10_1186_s12889_024_18515_9 crossref_primary_10_1093_ajcn_nqy059 crossref_primary_10_1186_s13063_017_2271_2 crossref_primary_10_1017_S0007114523001241 crossref_primary_10_3945_ajcn_116_137497 crossref_primary_10_1007_s15006_014_3017_7 crossref_primary_10_1016_j_foodchem_2018_11_072 crossref_primary_10_3390_foods13142280 crossref_primary_10_1126_sciadv_abn3328 crossref_primary_10_1161_JAHA_122_026477 crossref_primary_10_1016_j_clnu_2020_11_022 crossref_primary_10_1155_2023_5586403 crossref_primary_10_3390_molecules26102834 crossref_primary_10_1016_j_arteri_2018_06_005 crossref_primary_10_1007_s13197_022_05460_x crossref_primary_10_1007_s00394_017_1487_y crossref_primary_10_3153_FH22032 crossref_primary_10_1093_advances_nmaa132 crossref_primary_10_1002_sim_7352 crossref_primary_10_1016_j_numecd_2024_06_024 crossref_primary_10_1016_j_mayocp_2018_06_008 crossref_primary_10_1001_jamainternmed_2018_2425 crossref_primary_10_1093_nutrit_nuw057 crossref_primary_10_1016_j_mayocp_2014_05_014 crossref_primary_10_1038_s41598_018_25919_2 crossref_primary_10_1093_aje_kwv146 crossref_primary_10_1155_2020_1496462 crossref_primary_10_1080_27697061_2023_2225095 crossref_primary_10_1038_s41430_023_01355_y crossref_primary_10_18632_oncotarget_19609 crossref_primary_10_1016_j_artere_2018_11_001 crossref_primary_10_1093_ajcn_nqz051 crossref_primary_10_1016_j_jhep_2017_08_005 crossref_primary_10_1016_j_jff_2024_106419 crossref_primary_10_1161_JAHA_122_025644 crossref_primary_10_1007_s00394_017_1591_z crossref_primary_10_1002_mnfr_202000489 crossref_primary_10_1016_j_tcm_2019_07_007 crossref_primary_10_1007_s10840_022_01421_8 crossref_primary_10_1177_0003319715603185 crossref_primary_10_1016_j_fct_2022_113472 crossref_primary_10_1016_j_amjmed_2024_03_038 crossref_primary_10_1186_s12872_021_02058_7 crossref_primary_10_3233_JAD_220591 crossref_primary_10_1007_s12181_015_0660_x crossref_primary_10_1007_s13668_014_0087_1 crossref_primary_10_3109_09637486_2015_1077795 crossref_primary_10_3390_nu16244257 crossref_primary_10_1124_mol_120_119412 crossref_primary_10_1249_MSS_0000000000001287 crossref_primary_10_12997_jla_2020_9_1_205 crossref_primary_10_1016_j_nupar_2023_10_002 crossref_primary_10_1007_s13530_019_0403_7 crossref_primary_10_1038_s41598_024_71426_y crossref_primary_10_1016_j_amjcard_2015_05_057 crossref_primary_10_1093_aje_kwu194 crossref_primary_10_1080_10408398_2020_1779175 crossref_primary_10_3153_FH21032 crossref_primary_10_1016_j_jstrokecerebrovasdis_2020_105452 crossref_primary_10_1093_eurheartj_ehy339 crossref_primary_10_1155_2017_5982809 crossref_primary_10_1016_j_nut_2016_12_021 crossref_primary_10_1080_14779072_2017_1287563 crossref_primary_10_1186_s12937_024_00931_7 crossref_primary_10_1002_fsn3_3931 crossref_primary_10_14233_ajchem_2022_23741 crossref_primary_10_1016_j_tet_2016_03_091 crossref_primary_10_1080_15548627_2021_2021494 crossref_primary_10_35366_105188 crossref_primary_10_4103_joacp_joacp_285_22 crossref_primary_10_1007_s15005_014_0812_8 crossref_primary_10_1056_NEJMra1816604 crossref_primary_10_3390_foods11152199 crossref_primary_10_1016_j_fct_2023_113629 crossref_primary_10_1093_jn_nxac094 crossref_primary_10_18261_ntfe_12_4_3 crossref_primary_10_1111_jfpp_16626 crossref_primary_10_5720_kjcn_2015_20_4_301 crossref_primary_10_1039_C7FO00388A crossref_primary_10_1080_10408398_2021_1963207 crossref_primary_10_31083_j_rcm2301041 crossref_primary_10_1161_CIRCULATIONAHA_115_017341 crossref_primary_10_1016_j_arteri_2022_09_002 crossref_primary_10_1016_j_phrs_2022_106596 crossref_primary_10_1016_j_numecd_2023_07_011 crossref_primary_10_1007_s00508_019_01565_0 crossref_primary_10_1017_S1368980017003093 crossref_primary_10_1038_s41598_021_03153_7 crossref_primary_10_1097_HJH_0000000000001940 crossref_primary_10_3390_nu13072218 crossref_primary_10_1097_CP9_0000000000000092 crossref_primary_10_3390_beverages5020037 crossref_primary_10_3389_fendo_2023_1169933 crossref_primary_10_1136_svn_2017_000130 crossref_primary_10_3390_jcm11112985 crossref_primary_10_2903_j_efsa_2015_4102 crossref_primary_10_3390_nu11030653 crossref_primary_10_1016_j_amjmed_2016_08_038 crossref_primary_10_1111_jgs_16467 crossref_primary_10_4103_abr_abr_174_24 crossref_primary_10_1179_1476830515Y_0000000018 crossref_primary_10_1038_s41430_018_0205_z crossref_primary_10_15407_fz67_04_037 crossref_primary_10_3390_nu15040994 crossref_primary_10_3390_nu15245031 crossref_primary_10_1016_j_jff_2018_04_011 crossref_primary_10_1093_nutrit_nuy014 crossref_primary_10_1159_000507026 crossref_primary_10_1016_j_atherosclerosis_2021_01_022 crossref_primary_10_3389_fnut_2024_1434704 crossref_primary_10_1016_j_ypmed_2019_105970 crossref_primary_10_1016_j_numecd_2024_08_004 crossref_primary_10_1038_s41598_017_02384_x crossref_primary_10_1080_10408398_2020_1750343 crossref_primary_10_5720_kjcn_2020_25_1_48 crossref_primary_10_4103_jfmpc_jfmpc_654_24 crossref_primary_10_1016_j_ekir_2024_01_024 crossref_primary_10_1016_j_numecd_2017_12_010 crossref_primary_10_1177_2047487320908385 crossref_primary_10_1111_ijcp_12919 crossref_primary_10_1016_j_etap_2015_02_002 crossref_primary_10_1038_s41467_021_22752_6 crossref_primary_10_1007_s11377_017_0193_x crossref_primary_10_1016_j_jacc_2018_02_085 crossref_primary_10_1002_mds_27836 crossref_primary_10_1016_j_fbp_2022_09_005 crossref_primary_10_1016_j_arr_2024_102581 crossref_primary_10_7759_cureus_9578 crossref_primary_10_1161_CIRCHEARTFAILURE_119_006799 crossref_primary_10_1002_mnfr_202000875 crossref_primary_10_3390_nu12051470 crossref_primary_10_3390_nu15183987 crossref_primary_10_1001_jamanetworkopen_2019_3109 crossref_primary_10_3390_nu10070808 crossref_primary_10_1111_eci_12627 crossref_primary_10_1038_s41569_022_00719_4 crossref_primary_10_1080_15502783_2024_2323919 crossref_primary_10_1093_eurjpc_zwac257 crossref_primary_10_3390_nu16183155 crossref_primary_10_1136_bmjopen_2017_017224 crossref_primary_10_1093_rheumatology_keae453 crossref_primary_10_3390_hearts5030020 crossref_primary_10_1016_j_jand_2021_03_014 crossref_primary_10_3390_nu15020312 crossref_primary_10_1017_jns_2022_78 crossref_primary_10_1080_09637486_2018_1466272 crossref_primary_10_1016_j_metop_2019_03_001 crossref_primary_10_3390_molecules28186556 crossref_primary_10_1016_j_pranut_2022_03_004 crossref_primary_10_1017_S0007114521002737 crossref_primary_10_1093_ajcn_nqab014 crossref_primary_10_1136_bmjmed_2022_000335 crossref_primary_10_1017_S0007114518002635 crossref_primary_10_3233_JAD_160116 crossref_primary_10_3390_nu16050730 crossref_primary_10_1002_ehf2_12684 crossref_primary_10_1097_HPC_0000000000000322 crossref_primary_10_1017_S1368980016001749 crossref_primary_10_1016_j_clnu_2016_11_013 crossref_primary_10_1016_j_jnutbio_2025_109869 crossref_primary_10_1371_journal_pone_0298123 crossref_primary_10_1093_eurheartj_ehad736 crossref_primary_10_1111_crj_12662 crossref_primary_10_3390_molecules28186440 crossref_primary_10_1007_s12603_022_1767_y crossref_primary_10_1097_ICO_0000000000002979 crossref_primary_10_1111_jfbc_12401 crossref_primary_10_1016_j_jand_2022_12_007 crossref_primary_10_1111_jhn_13145 crossref_primary_10_1097_CM9_0000000000002234 crossref_primary_10_1016_j_freeradbiomed_2020_07_020 crossref_primary_10_1097_WCO_0000000000000285 crossref_primary_10_1089_jcr_2017_0011 crossref_primary_10_1093_ije_dyab161 crossref_primary_10_1038_ejcn_2015_120 crossref_primary_10_1080_00015385_2022_2088170 crossref_primary_10_3390_ijms22010107 crossref_primary_10_1016_j_clnu_2020_05_052 crossref_primary_10_18632_oncotarget_8627 crossref_primary_10_1161_STROKEAHA_117_016993 crossref_primary_10_1371_journal_pone_0102276 crossref_primary_10_1161_CIRCULATIONAHA_115_015853 crossref_primary_10_1007_s10654_016_0202_2 crossref_primary_10_3390_nu14163339 crossref_primary_10_1007_s00394_018_1611_7 crossref_primary_10_1042_CS20190034 crossref_primary_10_1210_clinem_dgae552 crossref_primary_10_1007_s11886_019_1177_x crossref_primary_10_1038_ejcn_2016_52 crossref_primary_10_1039_D3FO04177H crossref_primary_10_3390_nu14010087 crossref_primary_10_7759_cureus_49991 crossref_primary_10_18632_oncotarget_23947 crossref_primary_10_1016_j_atherosclerosis_2024_117526 crossref_primary_10_1080_09637486_2018_1505834 crossref_primary_10_1371_journal_pmed_1003830 crossref_primary_10_1016_j_bone_2014_02_007 crossref_primary_10_29328_journal_acem_1001005 crossref_primary_10_2147_JMDH_S290990 crossref_primary_10_1371_journal_pone_0112006 crossref_primary_10_1016_j_numecd_2025_103855 crossref_primary_10_1534_genetics_119_302419 crossref_primary_10_1093_eurjpc_zwac189 crossref_primary_10_1017_S0007114520001075 crossref_primary_10_18632_oncotarget_24829 crossref_primary_10_1080_10408398_2018_1461607 crossref_primary_10_1097_CEJ_0000000000000226 crossref_primary_10_3390_ijms20174238 crossref_primary_10_1007_s40520_020_01645_6 crossref_primary_10_1093_ajcn_nqac148 crossref_primary_10_1093_ajcn_nqab299 crossref_primary_10_1016_j_cpcardiol_2024_102412 crossref_primary_10_3390_nu15030674 crossref_primary_10_1186_s13098_024_01417_6 crossref_primary_10_1007_s00421_016_3345_7 crossref_primary_10_1177_0017896918765024 crossref_primary_10_3390_ijerph17197020 crossref_primary_10_1001_jamadermatol_2018_3300 crossref_primary_10_1007_s40200_025_01592_x crossref_primary_10_3390_nu11092104 crossref_primary_10_1016_j_numecd_2018_05_007 crossref_primary_10_1016_j_numecd_2023_10_010 crossref_primary_10_3389_fnut_2021_739359 crossref_primary_10_1093_ije_dyw325 crossref_primary_10_1016_j_clnu_2016_03_021 crossref_primary_10_1016_j_clnu_2020_12_042 crossref_primary_10_1161_JAHA_117_005633 crossref_primary_10_1016_j_numecd_2021_05_014 crossref_primary_10_3390_nu15183910 crossref_primary_10_1089_thy_2018_0549 crossref_primary_10_1093_eurjpc_zwae251 crossref_primary_10_1007_s10654_019_00524_3 crossref_primary_10_1039_D4FO01900H crossref_primary_10_1186_s13690_024_01447_6 crossref_primary_10_2147_PRBM_S427867 crossref_primary_10_1371_journal_pone_0172631 crossref_primary_10_1038_s41598_017_06529_w crossref_primary_10_1016_j_artere_2023_05_010 crossref_primary_10_1016_j_ijcard_2016_03_006 crossref_primary_10_1038_s41467_022_28496_1 crossref_primary_10_1093_jn_nxy075 crossref_primary_10_1161_JAHA_115_003089 crossref_primary_10_1080_09637486_2017_1362690 crossref_primary_10_1016_j_clnu_2018_07_033 crossref_primary_10_3390_nu9030276 crossref_primary_10_1161_JAHA_120_016808 crossref_primary_10_1093_ajcn_nqaa312 crossref_primary_10_1038_s41598_022_15611_x crossref_primary_10_1080_09637486_2016_1256381 crossref_primary_10_3390_metabo12070654 crossref_primary_10_1007_s00115_014_4250_0 crossref_primary_10_1177_2047487320914443 crossref_primary_10_1016_j_cofs_2017_02_012 crossref_primary_10_1021_acs_jafc_7b04506 crossref_primary_10_1186_s12883_021_02411_5 crossref_primary_10_1016_j_atherosclerosis_2016_08_042 crossref_primary_10_1111_1753_0407_13258 crossref_primary_10_1016_j_talanta_2020_121563 crossref_primary_10_1016_j_clnu_2023_08_004 crossref_primary_10_3945_ajcn_117_153338 crossref_primary_10_1038_s41467_023_38410_y crossref_primary_10_1093_eurheartj_ehae871 crossref_primary_10_1002_mnfr_202100539 crossref_primary_10_1016_j_semerg_2019_02_015 crossref_primary_10_1146_annurev_nutr_071816_064941 crossref_primary_10_1007_s00394_021_02650_9 crossref_primary_10_3390_nu9080890 crossref_primary_10_1186_s12986_024_00798_9 crossref_primary_10_1016_j_heliyon_2020_e04886 crossref_primary_10_4103_jiag_jiag_53_23 crossref_primary_10_1007_s00394_018_1664_7 crossref_primary_10_1186_s12916_015_0447_8 crossref_primary_10_1016_j_amjmed_2018_05_021 crossref_primary_10_1038_s41598_018_34392_w crossref_primary_10_1016_j_explore_2016_02_013 crossref_primary_10_1093_jn_nxaa365 crossref_primary_10_3390_nu12103141 crossref_primary_10_1038_s41430_024_01478_w crossref_primary_10_1093_jn_nxaa126 crossref_primary_10_3748_wjg_v21_i37_10621 crossref_primary_10_1007_s00421_020_04521_3 crossref_primary_10_1016_j_hrthm_2024_11_047 crossref_primary_10_1016_j_jacc_2018_10_019 crossref_primary_10_3390_nu11071617 crossref_primary_10_1371_journal_pone_0167007 crossref_primary_10_1016_j_artere_2019_02_006 crossref_primary_10_1002_hep_27367 crossref_primary_10_1093_advances_nmaa177 crossref_primary_10_1161_JAHA_124_034365 crossref_primary_10_1016_j_arteri_2019_02_004 crossref_primary_10_1016_j_cbi_2024_111343 crossref_primary_10_1136_heartjnl_2014_306663 crossref_primary_10_3390_ph12030110 crossref_primary_10_1097_HJH_0000000000002353 crossref_primary_10_3390_nu15112469 crossref_primary_10_1111_jhn_12633 crossref_primary_10_2174_1381612825666191105111232 crossref_primary_10_1089_caff_2017_0011 crossref_primary_10_1158_1055_9965_EPI_20_1633 crossref_primary_10_3390_nu12020493 crossref_primary_10_3390_nu9070741 crossref_primary_10_1016_j_tcm_2021_08_004 crossref_primary_10_3389_fnut_2022_976020 crossref_primary_10_3389_fnut_2024_1375252 crossref_primary_10_1038_s41598_023_31857_5 crossref_primary_10_3390_nu13041275 crossref_primary_10_1371_journal_pone_0147762 crossref_primary_10_1590_s0104_59702019000100009 crossref_primary_10_1007_s11357_024_01262_5 crossref_primary_10_58502_DTT_23_0012 crossref_primary_10_1097_YCO_0000000000000333 crossref_primary_10_1590_0001_3765201720160509 crossref_primary_10_1038_s41386_024_01870_x crossref_primary_10_1016_j_acvd_2023_05_007 crossref_primary_10_1002_ana_25693 crossref_primary_10_1016_j_pcad_2018_02_002 crossref_primary_10_18632_aging_101287 crossref_primary_10_1007_s00394_017_1455_6 crossref_primary_10_3390_molecules21080974 crossref_primary_10_3390_nu16172848 crossref_primary_10_1186_s12937_020_00587_z crossref_primary_10_3945_ajcn_115_112755 crossref_primary_10_1007_s00216_016_9468_1 crossref_primary_10_1089_jcr_2016_0017 crossref_primary_10_3390_molecules21060807 crossref_primary_10_3390_nu13062084 crossref_primary_10_23921_amp_2020v4i1_94611 crossref_primary_10_1016_j_jafr_2025_101805 crossref_primary_10_1089_dia_2015_0017 crossref_primary_10_1016_j_jacc_2018_05_030 crossref_primary_10_1111_imj_13621 crossref_primary_10_1007_s10304_016_0059_1 crossref_primary_10_1186_s12916_024_03817_x crossref_primary_10_29219_fnr_v68_10458 crossref_primary_10_3390_nu10060705 crossref_primary_10_1158_1055_9965_EPI_15_0038_T crossref_primary_10_1093_ije_dyv083 |
| Cites_doi | 10.1093/ajcn/73.3.532 10.1016/j.amjmed.2012.03.008 10.1056/NEJMoa1112010 10.1161/atvbaha.109.201939 10.3945/ajcn.111.023648 10.1016/j.amjcard.2008.07.046 10.1097/00001648-199307000-00013 10.1016/j.numecd.2006.07.013 10.1136/jech.53.8.481 10.1136/hrt.72.3.269 10.1016/0895-4356(92)90051-N 10.1016/j.ahj.2009.07.006 10.1001/jama.295.10.1135 10.1161/strokeaha.107.504183 10.1093/oxfordjournals.aje.a114717 10.3945/ajcn.111.016667 10.1016/0091-7435(88)90006-0 10.1111/j.1365-2796.1995.tb01140.x 10.1093/aje/kwr226 10.1136/bmj.315.7109.629 10.1016/S0031-6997(24)01396-6 10.1161/circulationaha.108.826164 10.1146/annurev.nutr.17.1.305 10.3945/ajcn.110.004044 10.1161/strokeaha.111.677500 10.1056/NEJM198304073081405 10.1136/jech.51.4.461 10.1056/NEJM198911233212103 10.1161/strokeaha.110.603787 10.1093/ajcn/83.5.1039 10.1056/NEJM199010113231504 10.1016/j.mayocp.2013.06.020 10.1111/j.1365-2796.1991.tb00407.x 10.1016/1047-2797(94)90001-9 10.1016/0021-9150(87)90270-X 10.1111/j.0954-6820.1977.tb15745.x 10.1093/oxfordjournals.aje.a115684 10.1093/ajcn/76.6.1244 10.1056/NEJM197801262980403 10.1016/j.ijcard.2008.06.051 10.1371/journal.pgen.1002033 10.1016/j.ahj.2008.11.009 10.1001/jama.294.1.97 10.1136/jech.2009.097311 10.1212/WNL.0b013e3181fb443d 10.1007/s10654-013-9834-7 10.3945/jn.109.109314 10.1161/01.CIR.28.1.20 10.1056/NEJM197307122890203 10.1042/CS20040358 10.1093/jn/134.9.2381 10.1001/jama.283.15.2008 10.1161/circulationaha.107.712976 10.1017/S0007114510001923 10.1038/sj.ejcn.1600899 10.1017/S0007114507871650 10.1161/circheartfailure.112.967299 10.1002/jrsm.5 10.1161/circulationaha.105.598664 10.1016/S0895-4356(98)00023-7 10.1007/s00125-006-0435-9 10.2337/dc07-1952 10.1056/NEJM197603182941203 10.1136/bmj.300.6724.566 10.1093/oxfordjournals.aje.a116237 10.1001/archinte.160.22.3393 10.1097/01.ede.0000229444.55718.96 10.1093/ajcn/85.2.392 10.1016/j.ijcard.2003.11.013 |
| ContentType | Journal Article |
| Copyright | 2014 by the American College of Cardiology Foundation and the American Heart Association, Inc. 2015 INIST-CNRS |
| Copyright_xml | – notice: 2014 by the American College of Cardiology Foundation and the American Heart Association, Inc. – notice: 2015 INIST-CNRS |
| DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7X8 5PM |
| DOI | 10.1161/CIRCULATIONAHA.113.005925 |
| DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Anatomy & Physiology |
| EISSN | 1524-4539 |
| EndPage | 659 |
| ExternalDocumentID | PMC3945962 24201300 28231831 10_1161_CIRCULATIONAHA_113_005925 10.1161/CIRCULATIONAHA.113.005925 |
| Genre | Meta-Analysis Systematic Review Journal Article Research Support, N.I.H., Extramural |
| GrantInformation_xml | – fundername: NHLBI NIH HHS grantid: R01 HL060712 – fundername: NHLBI NIH HHS grantid: HL60712 |
| GroupedDBID | --- .-D .3C .XZ .Z2 01R 0R~ 0ZK 18M 1J1 29B 2FS 2WC 354 40H 4Q1 4Q2 4Q3 53G 5GY 5RE 5VS 6PF 71W 77Y 7O~ AAAAV AAAXR AAGIX AAHPQ AAIQE AAJCS AAMOA AAMTA AARTV AASOK AAUEB AAWTL AAXQO ABBUW ABDIG ABJNI ABOCM ABPMR ABPXF ABQRW ABXVJ ABZAD ACCJW ACDDN ACDOF ACEWG ACGFO ACGFS ACILI ACOAL ACRKK ACWDW ACWRI ACXNZ ACZKN ADBBV ADCYY ADGGA ADHPY AE3 AE6 AEETU AENEX AFCHL AFDTB AFEXH AFNMH AFUWQ AGINI AHMBA AHOMT AHQNM AHRYX AHVBC AIJEX AINUH AJCLO AJIOK AJNWD AJZMW ALKUP ALMA_UNASSIGNED_HOLDINGS AMJPA AMNEI ASPBG AVWKF AYCSE AZFZN BAWUL BOYCO BQLVK BYPQX C45 CS3 DIK DIWNM DU5 DUNZO E3Z EBS EJD EX3 F2K F2L F2M F2N F5P FCALG GX1 H0~ H13 HZ~ IKREB IKYAY IN~ JF9 JG8 JK3 JK8 K-A K-F K8S KD2 KMI KQ8 L-C L7B N9A N~7 N~B O9- OAG OAH OBH OCB ODMTH OGEVE OHH OHYEH OK1 OL1 OLB OLG OLH OLU OLV OLY OLZ OPUJH OVD OVDNE OVIDH OVLEI OVOZU OWBYB OWU OWV OWW OWX OWY OWZ OXXIT P2P PQQKQ RAH RLZ S4R S4S T8P TEORI TR2 UPT V2I VVN W2D W3M W8F WH7 WOQ WOW X3V X3W XXN XYM YFH YOC YSK YYM YZZ ZFV ZY1 ZZMQN ~H1 AAFWJ AAYXX CITATION .55 .GJ 1CY 41~ AAEJM AAQKA AASCR AASXQ AAYOK ABASU ABVCZ ABXYN ABZZY ACIJW ACLDA ACRZS ACXJB ADFPA ADNKB AEBDS AFBFQ AFFNX AFMBP AFSOK AHQVU AJJEV AJNYG AKCTQ AKULP ALMTX AMKUR AOHHW AOQMC BS7 C1A E.X EEVPB ERAAH FEDTE FL- FW0 GNXGY GQDEL HLJTE HVGLF H~9 IPNFZ IQODW J5H M18 MVM N4W NEJ N~M OCUKA ODA OHT ORVUJ OUVQU P-K R58 RIG TSPGW WHG X7M YQJ YXB YYP ZGI ZXP CGR CUY CVF ECM EIF NPM 7X8 5PM |
| ID | FETCH-LOGICAL-c5265-302fe99c9a0cf3176a7fd276a54ab7a96cafb8d56d3978502188fe6436768e0f3 |
| ISSN | 0009-7322 1524-4539 |
| IngestDate | Thu Aug 21 14:36:18 EDT 2025 Fri Jul 11 08:42:47 EDT 2025 Sat Jul 12 03:53:23 EDT 2025 Wed Apr 02 07:35:49 EDT 2025 Sun Jul 06 05:05:33 EDT 2025 Thu Apr 24 23:12:24 EDT 2025 Fri May 16 03:44:17 EDT 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 6 |
| Keywords | Consumption Evidence-based practice meta-analysis Cardiovascular disease Systematic review Risk cardiovascular diseases Coffee Long term Evidence-based medicine Phlebology Posology Metaanalysis Prospective Response Cohort study Risk factor Circulatory system Cardiology Dose Public health coffee |
| Language | English |
| License | CC BY 4.0 |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c5265-302fe99c9a0cf3176a7fd276a54ab7a96cafb8d56d3978502188fe6436768e0f3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 ObjectType-Undefined-4 |
| PMID | 24201300 |
| PQID | 1499132086 |
| PQPubID | 23479 |
| PageCount | 17 |
| ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_3945962 proquest_miscellaneous_1499132086 pubmed_primary_24201300 pascalfrancis_primary_28231831 crossref_citationtrail_10_1161_CIRCULATIONAHA_113_005925 crossref_primary_10_1161_CIRCULATIONAHA_113_005925 wolterskluwer_health_10_1161_CIRCULATIONAHA_113_005925 |
| PublicationCentury | 2000 |
| PublicationDate | 2014-February-11 |
| PublicationDateYYYYMMDD | 2014-02-11 |
| PublicationDate_xml | – month: 02 year: 2014 text: 2014-February-11 day: 11 |
| PublicationDecade | 2010 |
| PublicationPlace | Hagerstown, MD |
| PublicationPlace_xml | – name: Hagerstown, MD – name: United States |
| PublicationTitle | Circulation (New York, N.Y.) |
| PublicationTitleAlternate | Circulation |
| PublicationYear | 2014 |
| Publisher | by the American College of Cardiology Foundation and the American Heart Association, Inc Lippincott Williams & Wilkins |
| Publisher_xml | – name: by the American College of Cardiology Foundation and the American Heart Association, Inc – name: Lippincott Williams & Wilkins |
| References | e_1_3_3_50_2 e_1_3_3_16_2 e_1_3_3_18_2 e_1_3_3_39_2 e_1_3_3_12_2 e_1_3_3_37_2 Jazbec A (e_1_3_3_42_2) 2003; 21 e_1_3_3_58_2 e_1_3_3_14_2 e_1_3_3_35_2 e_1_3_3_56_2 e_1_3_3_33_2 e_1_3_3_54_2 e_1_3_3_10_2 e_1_3_3_31_2 e_1_3_3_52_2 Selb Semerl J (e_1_3_3_71_2) 2004; 45 e_1_3_3_73_2 e_1_3_3_40_2 e_1_3_3_61_2 e_1_3_3_5_2 e_1_3_3_9_2 e_1_3_3_27_2 e_1_3_3_29_2 e_1_3_3_23_2 e_1_3_3_48_2 e_1_3_3_69_2 e_1_3_3_25_2 e_1_3_3_46_2 e_1_3_3_67_2 e_1_3_3_44_2 e_1_3_3_65_2 e_1_3_3_3_2 e_1_3_3_21_2 e_1_3_3_63_2 e_1_3_3_51_2 e_1_3_3_74_2 e_1_3_3_70_2 e_1_3_3_17_2 e_1_3_3_19_2 e_1_3_3_38_2 e_1_3_3_13_2 e_1_3_3_36_2 e_1_3_3_59_2 e_1_3_3_15_2 e_1_3_3_34_2 (e_1_3_3_7_2) 1972; 2 e_1_3_3_32_2 e_1_3_3_55_2 e_1_3_3_11_2 e_1_3_3_30_2 e_1_3_3_53_2 e_1_3_3_72_2 e_1_3_3_62_2 e_1_3_3_60_2 e_1_3_3_6_2 Fredholm BB (e_1_3_3_57_2) 1999; 51 e_1_3_3_8_2 e_1_3_3_28_2 e_1_3_3_49_2 e_1_3_3_24_2 e_1_3_3_47_2 e_1_3_3_26_2 e_1_3_3_45_2 e_1_3_3_68_2 e_1_3_3_2_2 e_1_3_3_20_2 e_1_3_3_43_2 e_1_3_3_66_2 e_1_3_3_4_2 e_1_3_3_22_2 e_1_3_3_41_2 e_1_3_3_64_2 |
| References_xml | – ident: e_1_3_3_67_2 doi: 10.1093/ajcn/73.3.532 – ident: e_1_3_3_68_2 doi: 10.1016/j.amjmed.2012.03.008 – ident: e_1_3_3_12_2 doi: 10.1056/NEJMoa1112010 – ident: e_1_3_3_19_2 doi: 10.1161/atvbaha.109.201939 – ident: e_1_3_3_14_2 doi: 10.3945/ajcn.111.023648 – ident: e_1_3_3_52_2 doi: 10.1016/j.amjcard.2008.07.046 – ident: e_1_3_3_11_2 doi: 10.1097/00001648-199307000-00013 – ident: e_1_3_3_15_2 doi: 10.1016/j.numecd.2006.07.013 – ident: e_1_3_3_38_2 doi: 10.1136/jech.53.8.481 – ident: e_1_3_3_10_2 doi: 10.1136/hrt.72.3.269 – ident: e_1_3_3_39_2 doi: 10.1016/0895-4356(92)90051-N – ident: e_1_3_3_60_2 doi: 10.1016/j.ahj.2009.07.006 – ident: e_1_3_3_73_2 doi: 10.1001/jama.295.10.1135 – ident: e_1_3_3_56_2 doi: 10.1161/strokeaha.107.504183 – ident: e_1_3_3_20_2 doi: 10.1093/oxfordjournals.aje.a114717 – ident: e_1_3_3_55_2 doi: 10.3945/ajcn.111.016667 – ident: e_1_3_3_22_2 doi: 10.1016/0091-7435(88)90006-0 – ident: e_1_3_3_32_2 doi: 10.1111/j.1365-2796.1995.tb01140.x – ident: e_1_3_3_16_2 doi: 10.1093/aje/kwr226 – ident: e_1_3_3_33_2 doi: 10.1136/bmj.315.7109.629 – volume: 51 start-page: 83 year: 1999 ident: e_1_3_3_57_2 article-title: Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. publication-title: Pharmacol Rev doi: 10.1016/S0031-6997(24)01396-6 – ident: e_1_3_3_62_2 doi: 10.1161/circulationaha.108.826164 – ident: e_1_3_3_69_2 doi: 10.1146/annurev.nutr.17.1.305 – ident: e_1_3_3_63_2 doi: 10.3945/ajcn.110.004044 – ident: e_1_3_3_13_2 doi: 10.1161/strokeaha.111.677500 – ident: e_1_3_3_4_2 doi: 10.1056/NEJM198304073081405 – ident: e_1_3_3_34_2 doi: 10.1136/jech.51.4.461 – ident: e_1_3_3_6_2 doi: 10.1056/NEJM198911233212103 – ident: e_1_3_3_21_2 doi: 10.1161/strokeaha.110.603787 – ident: e_1_3_3_48_2 doi: 10.1093/ajcn/83.5.1039 – ident: e_1_3_3_24_2 doi: 10.1056/NEJM199010113231504 – ident: e_1_3_3_47_2 doi: 10.1016/j.mayocp.2013.06.020 – ident: e_1_3_3_28_2 doi: 10.1111/j.1365-2796.1991.tb00407.x – ident: e_1_3_3_30_2 doi: 10.1016/1047-2797(94)90001-9 – ident: e_1_3_3_5_2 doi: 10.1016/0021-9150(87)90270-X – ident: e_1_3_3_35_2 doi: 10.1111/j.0954-6820.1977.tb15745.x – ident: e_1_3_3_27_2 – ident: e_1_3_3_37_2 doi: 10.1093/oxfordjournals.aje.a115684 – volume: 21 start-page: 332 year: 2003 ident: e_1_3_3_42_2 article-title: Impact of coffee and other selected factors on general mortality and mortality due to cardiovascular disease in Croatia. publication-title: Journal of Health, Population, and Nutrition – ident: e_1_3_3_65_2 doi: 10.1093/ajcn/76.6.1244 – ident: e_1_3_3_3_2 doi: 10.1056/NEJM197801262980403 – ident: e_1_3_3_45_2 doi: 10.1016/j.ijcard.2008.06.051 – ident: e_1_3_3_74_2 doi: 10.1371/journal.pgen.1002033 – ident: e_1_3_3_58_2 doi: 10.1016/j.ahj.2008.11.009 – ident: e_1_3_3_49_2 doi: 10.1001/jama.294.1.97 – ident: e_1_3_3_66_2 doi: 10.1136/jech.2009.097311 – ident: e_1_3_3_72_2 doi: 10.1212/WNL.0b013e3181fb443d – ident: e_1_3_3_23_2 doi: 10.1007/s10654-013-9834-7 – volume: 2 start-page: 1278 year: 1972 ident: e_1_3_3_7_2 article-title: Coffee drinking and acute myocardial infarction: report from the Boston Collaborative Drug Surveillance Program. publication-title: Lancet – ident: e_1_3_3_18_2 doi: 10.3945/jn.109.109314 – ident: e_1_3_3_2_2 doi: 10.1161/01.CIR.28.1.20 – ident: e_1_3_3_8_2 doi: 10.1056/NEJM197307122890203 – ident: e_1_3_3_61_2 doi: 10.1042/CS20040358 – ident: e_1_3_3_44_2 doi: 10.1093/jn/134.9.2381 – ident: e_1_3_3_25_2 doi: 10.1001/jama.283.15.2008 – ident: e_1_3_3_50_2 doi: 10.1161/circulationaha.107.712976 – ident: e_1_3_3_64_2 doi: 10.1017/S0007114510001923 – ident: e_1_3_3_53_2 doi: 10.1038/sj.ejcn.1600899 – ident: e_1_3_3_54_2 doi: 10.1017/S0007114507871650 – volume: 45 start-page: 775 year: 2004 ident: e_1_3_3_71_2 article-title: Coffee and alcohol consumption as triggering factors for sudden cardiac death: case-crossover study. publication-title: Croat Med J – ident: e_1_3_3_17_2 doi: 10.1161/circheartfailure.112.967299 – ident: e_1_3_3_29_2 doi: 10.1002/jrsm.5 – ident: e_1_3_3_46_2 doi: 10.1161/circulationaha.105.598664 – ident: e_1_3_3_36_2 doi: 10.1016/S0895-4356(98)00023-7 – ident: e_1_3_3_41_2 doi: 10.1007/s00125-006-0435-9 – ident: e_1_3_3_51_2 doi: 10.2337/dc07-1952 – ident: e_1_3_3_9_2 doi: 10.1056/NEJM197603182941203 – ident: e_1_3_3_26_2 doi: 10.1136/bmj.300.6724.566 – ident: e_1_3_3_31_2 doi: 10.1093/oxfordjournals.aje.a116237 – ident: e_1_3_3_40_2 doi: 10.1001/archinte.160.22.3393 – ident: e_1_3_3_70_2 doi: 10.1097/01.ede.0000229444.55718.96 – ident: e_1_3_3_43_2 doi: 10.1093/ajcn/85.2.392 – ident: e_1_3_3_59_2 doi: 10.1016/j.ijcard.2003.11.013 |
| SSID | ssj0006375 |
| Score | 2.5974393 |
| SecondaryResourceType | review_article |
| Snippet | BACKGROUND—Considerable controversy exists on the association between coffee consumption and cardiovascular disease (CVD) risk. A meta-analysis was performed... Considerable controversy exists on the association between coffee consumption and cardiovascular disease (CVD) risk. A meta-analysis was performed to assess... |
| SourceID | pubmedcentral proquest pubmed pascalfrancis crossref wolterskluwer |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 643 |
| SubjectTerms | Biological and medical sciences Blood and lymphatic vessels Cardiology. Vascular system Cardiovascular Diseases - mortality Coffee - adverse effects Coronary Disease - mortality Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous Heart Failure - mortality Humans Medical sciences Nonlinear Dynamics Prospective Studies Risk Factors Stroke - mortality |
| Title | Long-Term Coffee Consumption and Risk of Cardiovascular Disease: A Systematic Review and a Dose–Response Meta-Analysis of Prospective Cohort Studies |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/24201300 https://www.proquest.com/docview/1499132086 https://pubmed.ncbi.nlm.nih.gov/PMC3945962 |
| Volume | 129 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3bbtNAEF2FIlVIFYKWS7hUWwnx5uLLZm3zFiVAQA2qQiLlzVo7u03aJI5yEYLv4OP4HGa8a8dWgih9cSIn64vm7M7MzswZQt5gbCmQ4OS40pYWC-PECoXrWdwPR4nPueAOViN3v_LOgH0ZNoa12u9S1tJmHZ8nP_fWldxFqnAO5IpVsv8h2eKicAK-g3zhCBKG461kfJHOr6w-rK0wrZWSMmu_CfJZ5znGPZM43qpmnbZ1VEZXpX_bcjkblv2MvxVM65W0ejqFFua-XAurzGByuUzzKk247Ris-EpOYk5-MFkmpkHYvr4_pX2Itmmu0s11Ke4RjDdZx-SluN5k27TjyXQhStEjuPC13hiexZObQsNgTVZbI72XxmbD12xtOAyzoc3Smy_XoeV7unD5XJoV2mUWa2gGpGIJN0872VmQuSaBMrqda_bxXbXBUW20PvdagwtNQtxpYrebc6zN1YXZJTgtZhmewLjBsK-91aRFfuNlt-WFDBsb3SP3XXBgsLfGp-E2-Yh7fiPv8YcveEjOzHO8--tTIG-1uWXFiDpaAHrEVOlGLPs8pd2E36PvKSZjrG6yWoySRdV_RB4aV4g2Na4fk5qcH5MTwNg6nf2gb2mWnJxFfY7JYdfkgJyQXwXqqUY9LaGeAnYpop6milZRTw3q39Mm3WKeasxn4wStYJ5WMI8XLGGeasxTg_knZPDxQ7_VsUxvESvBhhCWZ7tKhmESCjtRYENz4auRCx8NJmJfhDwRKg5GDT4Cgz1ooCUcKAlo4uCfS1t5T8nBPJ3L54TGNnNs7CiqYsVipkJfMBW74UiMcDSrkyAXVpQY4n3s_zKNMgecO1FV5HDOi7TI68Qthi40-8xtBp1WEFGMdDHkH3hOnZzlEIlAmWCEUMxlullFDgN30XPtgNfJMw2Z7WiDvTrxK2Aq_oBE9dVf5pNxRlhv5kKd8ArsIl3q_e83enHnW74kD7YLyytysF5u5GvwItbxaTYh_wCwaxos |
| linkProvider | Geneva Foundation for Medical Education and Research |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Long-Term+Coffee+Consumption+and+Risk+of+Cardiovascular+Disease%3A+A+Systematic+Review+and+a+Dose-Response+Meta-Analysis+of+Prospective+Cohort+Studies&rft.jtitle=Circulation+%28New+York%2C+N.Y.%29&rft.au=Ding%2C+Ming&rft.au=Bhupathiraju%2C+Shilpa+N&rft.au=Satija%2C+Ambika&rft.au=van+Dam%2C+Rob+M&rft.date=2014-02-11&rft.issn=0009-7322&rft.eissn=1524-4539&rft.volume=129&rft.issue=6&rft.spage=643&rft.epage=659&rft_id=info:doi/10.1161%2FCIRCULATIONAHA.113.005925&rft_id=info%3Apmid%2F24201300&rft.externalDocID=PMC3945962 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0009-7322&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0009-7322&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0009-7322&client=summon |